Browse studies

Find your next paid study

26,914 recruiting studies available now

A Phase I, Multicenter, Dose Finding and Dose Confirmation Study to Investigate the Pharmacokinetics, and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy (ARTEMIDE-subQ)

The purpose of this study is to determine the subcutaneous (SC) dose that gives rilvegostomig exposure comparable to the intravenous (IV) exposure, and to eval…

Advanced Solid Tumors

Estimated

~$10 – $7,500

AstraZenecaNCT07161414

Observational

Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms: A Trial of tDCS and Cognitive Training 3-12 Months Post-mTBI

This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as …

Persistent Post Concussion SyndromeMild Traumatic Brain Injury

Estimated

~$10 – $6,250

University of MinnesotaNCT07246993

Phase 1

Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency

This is a Phase I/II non-randomized clinical trial of ex vivo hematopoietic stem cell (HSC) gene transfer treatment for X-linked severe combined immunodeficien…

X-linked Severe Combined Immunodeficiency (XSCID)

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT01306019

Phase 3

A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator's Choice of Chemotherapy in Previously Treated Patients With HER2- Expressing Recurrent Endometrial Cancer

The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth factor rece…

Endometrial Cancer

Estimated

~$10 – $7,500

BioNTech SENCT06340568

A Study to Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

The goal of this clinical trial is to determine the prevalence of exocrine pancreatic insufficiency (EPI) in a population of pediatric and adult participants w…

Exocrine Pancreatic Insuficiency

Estimated

~$10 – $1,050

Digestive Care, Inc.NCT07335523

Phase 1

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

Background: \- The blood-brain barrier separates the brain from the rest of the body. Epilepsy is a neurological disease that causes seizures. It can affect t…

Epilepsy

Estimated

~$10 – $5,625

National Institute of Neurological Disorders and Stroke (NINDS)NCT02531880

Evaluation for NCI Surgery Branch Clinical Research Protocols

Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tu…

Synovial Cell CancerMelanomaColorectal Cancer+2 more

Estimated

~$10 – $675

National Cancer Institute (NCI)NCT00001823

Phase 2

Targeted Agent and Profiling Utilization Registry (TAPUR) Study

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a geno…

Lymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors

Estimated

~$10 – $6,250

American Society of Clinical OncologyNCT02693535

The Evaluation and Management of Endocrine-Related Conditions and Physiology

Background: Endocrine disorders involve changes to glands that produce hormones. Hormones are released by these glands into the blood so they can direct the f…

Endocrine Disease

Estimated

~$10 – $675

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT03867448

Cutaneous Tumorigenesis in Patients With Tuberous Sclerosis

Tuberous sclerosis is a rare, hereditary disease in which patients develop multiple tumors. Although not cancerous, the tumors can affect various organs, inclu…

Tuberous Sclerosis

Estimated

~$10 – $675

National Heart, Lung, and Blood Institute (NHLBI)NCT00001975

Phase 3

A Long-term, Open-label Study to Evaluate the Safety and Efficacy of Orally Administered Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

This is a Phase 3, multicenter, long-term, open-label study to evaluate the safety and efficacy of once-daily orally administered deucrictibant extended-releas…

Hereditary Angioedema (HAE)

Estimated

~$10 – $7,500

Pharvaris Netherlands B.V.NCT06679881

Phase 2

A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Usnoflast Administered to Adult Subjects With ALS

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS)

Estimated

~$10 – $8,750

Zydus Therapeutics Inc.NCT07023835